CD8A and hepatocellular carcinoma: The NAFLD-HCC GM was also associated with an immunosuppressive milieu characterized by altered expansion of regulatory T cells (Tregs) and decreased CD8+ T cells, paving the way for gut-modulating therapeutic strategies to potentiate immunotherapy in HCC.